Univercells Technologies is using innovative technology to redefine the concepts of scale and flexibilty.

Featuring the first structured fixed-bed design, the scale-X bioreactor portfolio solves the challenges of capacity and scalability in a reduced physical footprint. The bioreactors create a truly homogeneous environment to increase cell density without aggregation while boosting specific productivity to make each cell deliver more.

From proof-of-concept to commercialization, the scale-X bioreactor portfolio delivers:

• Intensification, producing more in a reduced footprint
• Flexibility, accommodating viral production from in suspension and adherent cells
• Reliability, with robust and consistent processes
• Scalability, accelerating time-to-market